US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

GNI Group Ltd.

12.02

0.0000

Volume:- -

Turnover:- -

Market Cap:601.91M

PE:38.87

High:12.02

Open:12.02

Low:12.02

Close:12.02

Loading ...

Overview Company News Filings

Company Profile

Company Name:

GNI Group Ltd.

Exchange:

PINK LIMITED

Establishment Date:

2001

Employees:

867

Office Location:

Nihonbashi-Honcho YS Building,3rd Floor,2-2-2 Nihonbashi-Honcho,Chuo-ku,Tokyo,Japan

Website:

- -

Zip Code:

103-0023

Phone:

Fax:

81 3 6214 3668

Introduction:

GNI Group Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial phase II and pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, it is involved in developing F351, which is in Phase II clinical trial for the treatment of liver fibrosis; and F573 that is in pre-clinical phase for the treatment of acute on chronic liver failure, as well as Tamibarotene for the treatment of acute promyelocytic leukemia. The company was founded in 2001 and is headquartered in Tokyo, Japan.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GNIIF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNIIF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNIIF\",,,,,undefined,":{"symbol":"GNIIF","market":"US","secType":"STK","nameCN":"GNI Group Ltd.","latestPrice":12.02,"timestamp":1747425600000,"preClose":12.02,"halted":0,"volume":0,"delay":15,"floatShares":50075700,"shares":50075700,"eps":0.3092,"marketStatus":"Market Closed","change":0,"latestTime":"05-16 16:00:00 EDT Delay","open":12.02,"high":12.02,"low":12.02,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.3092,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747641600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":12.02,"volumeRatio":1.25000125000125},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNIIF\",,,,,undefined,":{"symbol":"GNIIF","floatShares":50075700,"roa":"1.45%","roe":"-0.02%","lyrEps":0.280613,"volumeRatio":1.25000125000125,"shares":50075700,"dividePrice":0,"high":12.02,"amplitude":0,"preClose":12.02,"low":12.02,"week52Low":12.02,"pbRate":"2.41","psRate":"3.71","week52High":38.8,"institutionHeld":0,"latestPrice":12.02,"eps":0.3092,"divideRate":0,"volume":0,"delay":15,"ttmEps":0.3092,"open":12.02,"prevYearClose":19.88,"prevWeekClose":12.02,"prevMonthClose":12.02,"prevQuarterClose":19.1,"fiveDayClose":12.02,"twentyDayClose":12.02,"sixtyDayClose":19.88},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":26764279,"yearFounded":2001,"employeeNum":867,"address":"Nihonbashi-Honcho YS Building,3rd Floor,2-2-2 Nihonbashi-Honcho,Chuo-ku,Tokyo,Japan","zipCode":"103-0023","officePhone":"81 3 6214 3600","officeFax":"81 3 6214 3668"},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"description":"GNI Group Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. It provides Etuary for the treatment of idiopathic pulmonary fibrosis. The company is also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial phase II and pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, it is involved in developing F351, which is in Phase II clinical trial for the treatment of liver fibrosis; and F573 that is in pre-clinical phase for the treatment of acute on chronic liver failure, as well as Tamibarotene for the treatment of acute promyelocytic leukemia. The company was founded in 2001 and is headquartered in Tokyo, Japan.","exchange":"PINK LIMITED","name":"GNI Group Ltd.","nameEN":"GNI Group Ltd."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GNIIF\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNIIF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2023-01-26","symbol":"GNIIF","reason":null,"defaultRemindTime":1674743400000,"announcedDate":"2023-01-25","type":"delisting","dateTimestamp":1674709200000},{"date":"2022-11-14","symbol":"GNIIF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1668416400000,"name":null,"time":"Pre-Market","dateTimestamp":1668402000000,"actualEps":null},{"market":"US","date":"2022-08-15","symbol":"GNIIF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1660536000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-09-02","symbol":"GNIIF","type":"split","dateTimestamp":1567396800000,"forFactor":1,"toFactor":3,"ratio":0.333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNIIF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNIIF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1735012800000}}}